| Name | Title | Contact Details |
|---|
MCPN provides excellent health-related services focusing on the underserved. MCPN has one of the largest population bases of any community health center in Colorado. MCPN is dedicated to being a positive work place with employees that are committed to being focused and disciplined team members. MCPN is also dedicated to taking care of our patients and our employees to ensure the best quality of life. Career Opportunities ! MCPN is committed to quality growth and is interested in speaking with unique individuals who want more in a career. Currently we are looking for Family Practice Physicians, Physician Assistants, Nurse Practitioners, Dentists, Dental Hygienists, and other Business Professionals. We offer top compensation, world class benefits, flexible hours and a belief in work/life balance. We look forward to hearing from you! Make your career exceptional by joining us.
Healthways, a Sharecare company, is a global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities.
Veterans Evaluation Services is a company that supports the U.S. Department of Veterans Affairs in providing veterans and transitioning service members with the benefits theyve earned through their service to the country. They provide high quality, ti...
North Star Imaging is a Rogers, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.